Transcription of Public Assessment Report Repeat-Use Mutual Recognition ...
{{id}} {{{paragraph}}}
Example: bachelor of science
Public Assessment Report Repeat-Use Mutual Recognition ...
Public Assessment Report Repeat-Use Mutual Recognition Procedure VERSATIS 5% MEDICATED PLASTER LIDOCAINE 5% MEDICATED PLASTER (Lidocaine) Procedure No: UK/H/1040-1041/001/E03 UK Licence No: PL 21727/0016-0017 Grunenthal Limited MRPAR Versatis/Lidocaine 5% Medicated Plaster UK/H/1040-1041/001/E03 2 LAY SUMMARY VERSATIS 5% MEDICATED PLASTER LIDOCAINE 5% MEDICATED PLASTER (lidocaine) This is a summary of the Public Assessment Report (PAR) for Versatis/Lidocaine 5% Medicated Plaster (PL 21727/0016-0017).
Public Assessment Report . Repeat-Use Mutual Recognition Procedure . VERSATIS 5% MEDICATED PLASTER . LIDOCAINE 5% MEDICATED PLASTER (Lidocaine) Procedure No: UK/H/1040-1041/001/E03
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Public Assessment Report Mutual Recognition Procedure, Public Assessment Report, All About Regulatory Affairs, Assessment report, Mutual recognition, Performance Assessment, Public, Procedure, Performance, The Mutual Recognition and Decentralised Procedures, RECOMMENDATIONS ON MULTIPLE/DUPLICATE, RECOMMENDATIONS ON MULTIPLE/DUPLICATE APPLICATIONS, MUTUAL RECOGNITION AND DECENTRALISED PROCEDURES, WHO Drug Information